Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nitronal 5mg/5ml solution for infusion ampoules
0206010F0BGAAAU
|
Nitronal | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Percutol 2% ointment
0206010F0BHAAAF
|
Percutol | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Suscard Buccal 1mg tablets
0206010F0BIAAAJ
|
Suscard Buccal | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Suscard Buccal 2mg tablets
0206010F0BIABAK
|
Suscard Buccal | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Suscard Buccal 3mg tablets
0206010F0BIACAM
|
Suscard Buccal | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Suscard Buccal 5mg tablets
0206010F0BIADAN
|
Suscard Buccal | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Sustac 10mg modified-release tablets
0206010F0BJACAQ
|
Sustac | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Sustac 2.6mg modified-release tablets
0206010F0BJAAAL
|
Sustac | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Sustac 6.4mg modified-release tablets
0206010F0BJABAP
|
Sustac | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Trintek 10 transdermal patches
0206010F0BXABBI
|
Trintek | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Trintek 15 transdermal patches
0206010F0BXACBJ
|
Trintek | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Trintek 5 transdermal patches
0206010F0BXAABH
|
Trintek | Glyceryl trinitrate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.